Abstract:Background: Prevalence of diabetes has steadily increased over the last few decades with 1.5 million deaths reported in 2012 alone. Traditionally, analyzing patients with diabetes has remained a largely invasive approach. Wearable devices (WDs) make use of sensors historically reserved for hospital settings. WDs coupled with artificial intelligence (AI) algorithms show promise to help understand and conclude meaningful information from the gathered data and provide advanced and clinically meaningful analytics. Objective: This review aimed to provide an overview of AI-driven WD features for diabetes and their use in monitoring diabetes-related parameters. Methods: We searched 7 of the most popular bibliographic databases using 3 groups of search terms related to diabetes, WDs, and AI. A 2-stage process was followed for study selection: reading abstracts and titles followed by full-text screening. Two reviewers independently performed study selection and data extraction, and disagreements were resolved by consensus. A narrative approach was used to synthesize the data. Results: From an initial 3872 studies, we report the features from 37 studies post filtering according to our predefined inclusion criteria. Most of the studies targeted type 1 diabetes, type 2 diabetes, or both (21/37, 57%). Many studies (15/37, 41%) reported blood glucose as their main measurement. More than half of the studies (21/37, 57%) had the aim of estimation and prediction of glucose or glucose level monitoring. Over half of the reviewed studies looked at wrist-worn devices. Only 41% of the study devices were commercially available. We observed the use of multiple sensors with photoplethysmography sensors being most prevalent in 32% (12/37) of studies. Studies reported and compared >1 machine learning (ML) model with high levels of accuracy. Support vector machine was the most reported (13/37, 35%), followed by random forest (12/37, 32%). Conclusions: This review is the most extensive work, to date, summarizing WDs that use ML for people with diabetes, and provides research direction to those wanting to further contribute to this emerging field. Given the advancements in WD technologies replacing the need for invasive hospital setting devices, we see great advancement potential in this domain. Further work is needed to validate the ML approaches on clinical data from WDs and provide meaningful analytics that could serve as data gathering, monitoring, prediction, classification, and recommendation devices in the context of diabetes.

Artificial Intelligence-Based Digital Biomarkers for Type 2 Diabetes: A Review

Artificial Intelligence-Based Methods for Precision Medicine: Diabetes Risk Prediction

Artificial intelligence and machine learning in diabetes research

Utilizing Artificial Intelligence Among Patients With Diabetes: A Systematic Review and Meta-Analysis

Artificial intelligence for diabetic care

Artificial Intelligence in Diabetes Management: Revolutionizing the Diagnosis of Diabetes Mellitus; a Literature Review

Artificial Intelligence in Current Diabetes Management and Prediction

Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges

AI-based diabetes care: risk prediction models and implementation concerns

A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control

Artificial intelligence for diabetes care: current and future prospects

Artificial Intelligence for Diabetes Management and Decision Support: Literature Review

Type 2 Diabetes with Artificial Intelligence Machine Learning: Methods and Evaluation

Transforming Diabetes Care Through Artificial Intelligence: The Future Is Here

A scoping review of artificial intelligence-based methods for diabetes risk prediction

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus

Artificial Intelligence for Diabetes Case Management: The Intersection of Physical and Mental Health

Artificial Intelligence Algorithms for Treatment of Diabetes

Artificial intelligence in diabetes management: Advancements, opportunities, and challenges

Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development

Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review